Arevalo G
Department of Medicine, Hospital Privado Centro Medico de Caracas, San Bernardino, Venezuela.
Clin Chem. 1989 Mar;35(3):475-7.
In ambulatory patients, assay of free thyroxin (FT4) in serum correlates well with thyroid status and with results obtained by equilibrium dialysis. The validity of FT4 results has been questioned mainly in euthyroid patients with altered concentrations of thyroid hormone-binding proteins, as in nonthyroidal illness, hereditary analbuminemia, familial dysalbuminemic hyperthyroxinemia (FDH), and the presence of iodothyronine-binding antibodies. I present here a study of the binding of [125I]T4-derivative to serum proteins in the supernate, which is ordinarily discarded after determination of FT4 by one-step radioimmunoassay with dextran-coated charcoal used to separate the free and bound fractions. The results are expressed as a ratio, with results for a normal serum pool as reference. The average ratio was high in hyperthyroid subjects, 1.26 (SD 0.12, n = 25), and in hypoalbuminemia, 1.20 (SD 0.10, n = 15), and low in FDH, 0.62 (SD 0.11, n = 9), and hypothyroid subjects, 0.90 (SD 0.06, n = 20). In normal individuals it was 0.98 (SD 0.05, n = 30). Determination of the analog-binding rate complements the FT4 result and allows for the recognition of cases with abnormal binding by serum proteins, without recourse to other tests recommended for thyroid-function studies.
在门诊患者中,血清游离甲状腺素(FT4)测定结果与甲状腺状态以及平衡透析所得结果密切相关。FT4结果的有效性主要受到质疑,这些质疑主要来自甲状腺激素结合蛋白浓度改变的甲状腺功能正常患者,如患有非甲状腺疾病、遗传性无白蛋白血症、家族性异常白蛋白血症性甲状腺素血症(FDH)以及存在碘甲状腺原氨酸结合抗体的患者。在此,我展示了一项关于[125I]T4衍生物与上清液中血清蛋白结合情况的研究,该上清液通常在采用葡聚糖包被活性炭一步放射免疫法测定FT4以分离游离和结合部分后被丢弃。结果以比率表示,以正常血清池的结果作为参考。甲状腺功能亢进患者的平均比率较高,为1.26(标准差0.12,n = 25),低白蛋白血症患者为1.20(标准差0.10,n = 15),FDH患者较低,为0.62(标准差0.11,n = 9),甲状腺功能减退患者为0.90(标准差0.06,n = 20)。正常个体的平均比率为0.98(标准差0.05,n = 30)。测定类似物结合率可补充FT4结果,并有助于识别血清蛋白结合异常的病例,而无需借助推荐用于甲状腺功能研究的其他检测方法。